Home › Funds › Renaissance Technologies › RLYB
Renaissance Technologies position in RLYB
RALLYBIO CORP · Health Care
Latest position (Q2 2026)199.91K sh
Reported value held$3.20M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 52.72K | $368.00K | New |
| Q4 2022 | 13.80K | $91 | New |
| Q1 2024 | 488.10K | $903 | New |
| Q2 2024 | 340.70K | $456.54K | Reduce |
| Q3 2024 | 403.70K | $472.33K | Add |
| Q4 2024 | 441.32K | $423.67K | Add |
| Q1 2025 | 396.50K | $259.51K | Reduce |
| Q2 2025 | 485.03K | $163.94K | Add |
| Q3 2025 | 714.80K | $356.69K | Add |
| Q4 2025 | 835.69K | $573.37K | Add |
| Q1 2026 | 156.53K | $1.40M | Reduce |
| Q2 2026 | 199.91K | $3.20M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLYB
- Citadel Advisors 7.71M sh · $12.73M · Q2 2026
- Fidelity Management & Research (FMR) 794.72K sh · $12.72M · Q2 2026
- Viking Global Investors 524.35K sh · $8.39M · Q2 2026
- Vanguard Group 1.02M sh · $697.15K · Q4 2025
- Geode Capital Management 32.05K sh · $512.87K · Q2 2026
- BlackRock Inc 30.33K sh · $485.31K · Q2 2026
- Two Sigma Investments 16.62K sh · $265.90K · Q2 2026
- UBS Group AG 146 sh · $2.34K · Q2 2026
- Morgan Stanley 125 sh · $2.00K · Q2 2026
- Wells Fargo & Co 37 sh · $592 · Q2 2026
- JPMorgan Chase & Co 9 sh · $145 · Q2 2026